HIF-1 alpha Antibody and 1 more item

The University of Virginia awarded contract A207_PO-0445534-V3 to Cell Signaling Technology Inc. on August 8, 2026, for the procurement of specialized research antibodies. The contract encompasses two primary line items: 285 units of HIF-1 alpha Antibody and 315 units of TRF2 (D1Y5D) Rabbit Monoclonal Antibody, each priced at $1 per unit. The cumulative contract value totals $601, reflecting the unit-based pricing structure for these laboratory reagents. Delivery is directed to the buyer, with performance occurring in Virginia.

Cell Signaling Technology Inc. serves as the prime contractor responsible for fulfilling the antibody supply requirements under this procurement action. The contract represents a standard scientific materials acquisition typical of academic research institutions requiring validated immunological reagents for experimental applications. The HIF-1 alpha and TRF2 antibodies constitute essential tools for molecular and cellular biology research, enabling detection and analysis of hypoxia-inducible factor-1 alpha and telomeric repeat binding factor 2 proteins respectively.